Tech Company Financing Transactions

Axial Biotech Funding Round

Johnson & Johnson Development Corporation and Signal Peak Ventures participated in a $6 million Series B capital raise for Axial Biotech. The financing round was recorded on 3/18/2008.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

2749 East Parleys Way 200
Salt Lake City, UT 84109
USA

Phone

(801) 984-9100

Website

www.axialbiotech.com

Email Address

[email protected]

Overview

Axial Biotech, Inc. is a privately held, venture-backed company founded in 2002 by a group of internationally recognized spine surgeons and geneticists. The company is focused on developing and commercializing DNA-based pre-symptomatic and prognostic tests, as well as motion-preserving technologies, for common spinal disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Climaco

        

Chief Scientific Officer

Kenneth Ward

        

VP - Operations

Lesa Nelson

        

VP - R & D

Roberto Macina

        

VP - Sales

Eric Olson

        

Browse more venture capital transactions:

Prev: 3/18/2008: CafeMom.com venture capital transaction
Next: 3/18/2008: Luminous Medical venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary